VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 75 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $95,000 | +6.7% | 76,351 | +66.5% | 0.00% | 0.0% |
Q4 2021 | $89,000 | -44.0% | 45,864 | -20.8% | 0.00% | -50.0% |
Q3 2021 | $159,000 | -60.3% | 57,916 | -54.5% | 0.00% | -69.2% |
Q2 2021 | $401,000 | -37.4% | 127,418 | -57.6% | 0.01% | -45.8% |
Q1 2021 | $641,000 | -29.3% | 300,717 | -35.7% | 0.02% | -29.4% |
Q4 2020 | $907,000 | – | 467,436 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $32,135,000 | 11.34% |
VR Adviser, LLC | 16,047,286 | $43,970,000 | 5.65% |
COMMODORE CAPITAL LP | 5,123,509 | $14,038,000 | 3.70% |
Ghost Tree Capital, LLC | 2,000,000 | $5,480,000 | 1.60% |
EPIQ PARTNERS, LLC | 916,100 | $2,510,000 | 1.16% |
SILVERARC CAPITAL MANAGEMENT, LLC | 707,733 | $1,939,000 | 1.10% |
SPHERA FUNDS MANAGEMENT LTD. | 3,824,938 | $10,480,000 | 0.88% |
HighVista Strategies LLC | 438,239 | $1,201,000 | 0.80% |
Nicholas Investment Partners, LP | 2,786,354 | $7,635,000 | 0.56% |
NEA Management Company, LLC | 16,302,596 | $44,669,000 | 0.53% |